Diabetes pills may fight fatty liver, study finds
NCT ID NCT06117137
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a class of diabetes drugs called SGLT2 inhibitors can improve fatty liver disease in people with type 2 diabetes. 150 adults took the drugs for 6 months, and researchers measured changes in liver stiffness, fat levels, and blood sugar control. The goal was to see if these medications could help manage both conditions together.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER, NONALCOHOLIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of medicine Sohag university hospital
Sohag, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Taste test: asian mediterranean diet for fatty liver
- Reishi mushroom tested as fatty liver treatment in new study
- Orange you glad you ate that? study tests fruit against fatty liver
- New drug shows promise against fatty liver disease in major trial
- Time-Restricted eating may tame fatty liver in lean adults
- Online diet program shows promise for fatty liver